Wild, Mirjam GauriMirjam GauriWildPraz, Fabien DanielFabien DanielPrazWenaweser, Peter MartinPeter MartinWenaweser2024-09-022024-09-022020-05-15https://boris-portal.unibe.ch/handle/20.500.12422/37741Valvular heart disease is responsible for a high rate of morbidity and mortality, especially in the elderly population. With the emergence of new transcatheter treatment options, the therapeutic spectrum for patients with valvular heart disease has considerably expanded during the past years. Interventional treatment of the mitral and tricuspid valve requires an individualized and versatile approach owing to the different etiologies of valvular dysfunction and the complex anatomy of the atrioventricular valves. This article aims to review recent developments, summarize the evidence, indications and limitations of the available systems, and provide a glimpse into the future of transcatheter interventions for the treatment of mitral and tricuspid valve disease.enannuloplasty cardioband edge-to-edge repair mitraclip mitral interventions pascal tricuspid interventions valvular heart disease600 - Technology::610 - Medicine & healtharticle10.7892/boris.1476453250008310.3389/fcvm.2020.00061